| Mashovin Home Health Care, Inc | |
| 12131 E Skelly Drive, Tulsa, Oklahoma 74128 | |
| (918) 245-3337 | |
| Not Available |
| Name | Mashovin Home Health Care, Inc |
|---|---|
| Location | 12131 E Skelly Drive, Tulsa, Oklahoma |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Home Health Aide |
| Medicare ID | 377682 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 74012, 74015, 74017, 74036, 74066, 74104, 74106, 74107, 74110, 74112, 74115, 74119, 74126, 74127, 74129, 74133, 74136, 74146, 74401, 74467 |
| NPI Number | 1881753572 |
| Organization Name | MASHOVIN HOME HEALTH CARE, INC. |
| Address | 12131 East Skelly Drive, Tulsa, OK 74128 |
| Phone Number | 918-245-3337 |
News Archive
Dong-A Pharmaceutical Co., Ltd. and Dong-A PharmTech, Co. Ltd. announced today that it has completed a 240 patient once-a-day dosing clinical study of udenafil, its new long acting phosphodiesterase type 5 (PDE-5) inhibitor for erectile dysfunction (ED).
Inherited mutations in genes that function to repair DNA may contribute to metastatic prostate cancer more than previously recognized, according to a study out today in the New England Journal of Medicine.
The American Institute of Ultrasound in Medicine (AIUM) and American Urological Association (AUA) are proud to announce the collaborative development of practice and training guidelines in the practice of urologic ultrasound which has led to the availability of practice accreditation through the AIUM.
The feds have promised to turn up the heat on providers, real and phony, who steal from and game the system. ... Lawmakers and President Barack Obama are demanding that the CMS and their partners in law enforcement do more to stem the wasted healthcare dollars gushing out of the Treasury like oil into the Gulf of Mexico.
Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration issued a Complete Response Letter for the New Drug Application for dasotraline, a novel dual-acting dopamine and norepinephrine reuptake inhibitor, for the treatment of attention-deficit hyperactivity disorder.
› Verified 3 days ago
| Quality Rating: | Not Available* |
| * The number of patient episodes for this measure is too small to report. | |
News Archive
Dong-A Pharmaceutical Co., Ltd. and Dong-A PharmTech, Co. Ltd. announced today that it has completed a 240 patient once-a-day dosing clinical study of udenafil, its new long acting phosphodiesterase type 5 (PDE-5) inhibitor for erectile dysfunction (ED).
Inherited mutations in genes that function to repair DNA may contribute to metastatic prostate cancer more than previously recognized, according to a study out today in the New England Journal of Medicine.
The American Institute of Ultrasound in Medicine (AIUM) and American Urological Association (AUA) are proud to announce the collaborative development of practice and training guidelines in the practice of urologic ultrasound which has led to the availability of practice accreditation through the AIUM.
The feds have promised to turn up the heat on providers, real and phony, who steal from and game the system. ... Lawmakers and President Barack Obama are demanding that the CMS and their partners in law enforcement do more to stem the wasted healthcare dollars gushing out of the Treasury like oil into the Gulf of Mexico.
Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration issued a Complete Response Letter for the New Drug Application for dasotraline, a novel dual-acting dopamine and norepinephrine reuptake inhibitor, for the treatment of attention-deficit hyperactivity disorder.
› Verified 3 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | Not Available |
| Health team communicated well with them | Not Available |
| Health team discussed medicines, pain, and home safety | Not Available |
| How patients rated overall care from agency | Not Available |
News Archive
Dong-A Pharmaceutical Co., Ltd. and Dong-A PharmTech, Co. Ltd. announced today that it has completed a 240 patient once-a-day dosing clinical study of udenafil, its new long acting phosphodiesterase type 5 (PDE-5) inhibitor for erectile dysfunction (ED).
Inherited mutations in genes that function to repair DNA may contribute to metastatic prostate cancer more than previously recognized, according to a study out today in the New England Journal of Medicine.
The American Institute of Ultrasound in Medicine (AIUM) and American Urological Association (AUA) are proud to announce the collaborative development of practice and training guidelines in the practice of urologic ultrasound which has led to the availability of practice accreditation through the AIUM.
The feds have promised to turn up the heat on providers, real and phony, who steal from and game the system. ... Lawmakers and President Barack Obama are demanding that the CMS and their partners in law enforcement do more to stem the wasted healthcare dollars gushing out of the Treasury like oil into the Gulf of Mexico.
Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration issued a Complete Response Letter for the New Drug Application for dasotraline, a novel dual-acting dopamine and norepinephrine reuptake inhibitor, for the treatment of attention-deficit hyperactivity disorder.
› Verified 3 days ago
The patient survey data of Mashovin Home Health Care, Inc is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 70 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 74 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 78 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 75 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 48 | 78 |
News Archive
Dong-A Pharmaceutical Co., Ltd. and Dong-A PharmTech, Co. Ltd. announced today that it has completed a 240 patient once-a-day dosing clinical study of udenafil, its new long acting phosphodiesterase type 5 (PDE-5) inhibitor for erectile dysfunction (ED).
Inherited mutations in genes that function to repair DNA may contribute to metastatic prostate cancer more than previously recognized, according to a study out today in the New England Journal of Medicine.
The American Institute of Ultrasound in Medicine (AIUM) and American Urological Association (AUA) are proud to announce the collaborative development of practice and training guidelines in the practice of urologic ultrasound which has led to the availability of practice accreditation through the AIUM.
The feds have promised to turn up the heat on providers, real and phony, who steal from and game the system. ... Lawmakers and President Barack Obama are demanding that the CMS and their partners in law enforcement do more to stem the wasted healthcare dollars gushing out of the Treasury like oil into the Gulf of Mexico.
Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration issued a Complete Response Letter for the New Drug Application for dasotraline, a novel dual-acting dopamine and norepinephrine reuptake inhibitor, for the treatment of attention-deficit hyperactivity disorder.
› Verified 3 days ago
Hillcrest Regional Home Health South Location: 7600 South Lewis Ave, Tulsa, Oklahoma 74136 Ratings: NA Phone: (918) 579-7842 | |
St John Home Care, Llc Location: 4720 South Harvard, Suite 202, Tulsa, Oklahoma 74135 Ratings: Phone: (918) 747-7901 | |
Saint Francis Home Health Location: 6600 S Yale Ave, Ste 200, Tulsa, Oklahoma 74136 Ratings: Phone: (918) 488-6888 | |
Live Well Home Care, Llc Location: 8165 S Mingo Road, Suite 102, Tulsa, Oklahoma 74133 Ratings: NA Phone: (918) 710-5103 | |
Interim Healthcare Of Tulsa Location: 2828 East 51st Street, Ste 102, Tulsa, Oklahoma 74105 Ratings: Phone: (918) 749-9933 | |
Kindred At Home Iii Location: 5314 South Yale, Suite 500, Tulsa, Oklahoma 74135 Ratings: NA Phone: (918) 488-6153 |